Article
NPAS2 Promotes MASLD and Hepatocarcinogenesis through SIRT1-Mediated PPARγ Suppression
2025-12-03
Abstract excerpt
<title>Abstract</title> <p> Emerging evidence suggests a link between circadian disruption and metabolic dysfunction-associated steatotic liver disease (MASLD), although the precise mechanisms are not yet fully understood. As a central circadian regulator, the role of NPAS2 in the pathogenesis and progression of MASLD to hepatocellular carcinoma (HCC) is not well characterized. This study aimed to clarify the fu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 42d4ae1c-14b8-528c-ad2b-b6779d2869fa
- DOI
- 10.21203/rs.3.rs-8137044/v1
